Everest Organics Limited (EVERESTO.BO)
INR 310.0
(0.4%)
INR 310.0
(0.4%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 51.9 Million INR | 248.2% |
| 2022 | -35.02 Million INR | -227.81% |
| 2021 | 27.4 Million INR | -85.96% |
| 2020 | 195.17 Million INR | 3.66% |
| 2019 | 188.28 Million INR | 25.54% |
| 2018 | 149.97 Million INR | 240.47% |
| 2017 | 44.04 Million INR | 23.74% |
| 2016 | 35.59 Million INR | 2.15% |
| 2015 | 34.84 Million INR | -34.25% |
| 2014 | 52.99 Million INR | 52.15% |
| 2013 | 34.83 Million INR | 6.03% |
| 2012 | 32.85 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -51.25 Million INR | -562.65% |
| 2023 Q4 | 11.07 Million INR | -24.55% |
| 2023 Q3 | 14.68 Million INR | 0.0% |
| 2023 FY | 51.9 Million INR | 248.2% |
| 2023 Q1 | 12.27 Million INR | 20.24% |
| 2023 Q2 | 14.68 Million INR | 19.62% |
| 2022 FY | -35.02 Million INR | -227.81% |
| 2022 Q1 | 16.44 Million INR | 70.28% |
| 2022 Q2 | -35.87 Million INR | -318.12% |
| 2022 Q3 | -35.87 Million INR | 0.0% |
| 2022 Q4 | 10.2 Million INR | 128.45% |
| 2021 Q3 | 6.11 Million INR | 127.79% |
| 2021 Q1 | 32.52 Million INR | -4.19% |
| 2021 FY | 27.4 Million INR | -85.96% |
| 2021 Q2 | -21.99 Million INR | -167.62% |
| 2021 Q4 | 9.66 Million INR | 58.05% |
| 2020 Q4 | 33.95 Million INR | -35.94% |
| 2020 FY | 195.17 Million INR | 3.66% |
| 2020 Q3 | 52.99 Million INR | -7.5% |
| 2020 Q2 | 57.29 Million INR | 6.11% |
| 2020 Q1 | 53.99 Million INR | -19.58% |
| 2019 FY | 188.28 Million INR | 25.54% |
| 2019 Q2 | 37.54 Million INR | -32.56% |
| 2019 Q1 | 55.67 Million INR | 16.46% |
| 2019 Q3 | 36.1 Million INR | -3.84% |
| 2019 Q4 | 67.13 Million INR | 85.97% |
| 2018 Q3 | 51.17 Million INR | 37.66% |
| 2018 Q2 | 37.17 Million INR | 107.49% |
| 2018 Q1 | 17.91 Million INR | 179.79% |
| 2018 Q4 | 47.8 Million INR | -6.59% |
| 2018 FY | 149.97 Million INR | 240.47% |
| 2017 Q1 | 12.54 Million INR | 59.23% |
| 2017 Q4 | 6.4 Million INR | -52.14% |
| 2017 FY | 44.04 Million INR | 23.74% |
| 2017 Q3 | 13.38 Million INR | -13.52% |
| 2017 Q2 | 15.47 Million INR | 23.32% |
| 2016 Q4 | 7.87 Million INR | -35.69% |
| 2016 FY | 35.59 Million INR | 2.15% |
| 2016 Q1 | 8.55 Million INR | -66.97% |
| 2016 Q2 | 10.1 Million INR | 18.11% |
| 2016 Q3 | 12.25 Million INR | 21.28% |
| 2015 Q1 | 10.18 Million INR | -54.84% |
| 2015 Q3 | 6.25 Million INR | 193.11% |
| 2015 Q2 | -6.72 Million INR | -166.02% |
| 2015 Q4 | 25.89 Million INR | 313.76% |
| 2015 FY | 34.84 Million INR | -34.25% |
| 2014 Q4 | 22.54 Million INR | 96.79% |
| 2014 Q3 | 11.45 Million INR | 18.15% |
| 2014 FY | 52.99 Million INR | 52.15% |
| 2014 Q2 | 9.69 Million INR | 0.0% |
| 2013 Q4 | 4.33 Million INR | -49.88% |
| 2013 Q1 | 10.8 Million INR | 717.97% |
| 2013 Q3 | 8.65 Million INR | -21.49% |
| 2013 FY | 34.83 Million INR | 6.03% |
| 2013 Q2 | 11.02 Million INR | 2.08% |
| 2012 FY | 32.85 Million INR | 0.0% |
| 2012 Q4 | 1.32 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 111.94 Million INR | 53.629% |
| Checkpoint Trends Limited | 6.28 Million INR | -726.104% |
| GUJARAT INJECT (KERALA) LTD. | 448.64 Thousand INR | -11469.95% |
| NATURO INDIABULL LIMITED | 17.74 Million INR | -192.571% |
| NEXUS SURGICAL AND MEDICARE LI | 2.92 Million INR | -1672.725% |
| Rajnish Wellness Limited | 41.71 Million INR | -24.45% |
| Rama Vision Limited | 57.87 Million INR | 10.304% |
| Vivo Bio Tech Limited | 119.9 Million INR | 56.709% |